Vigamox is a pharmaceutical raw material containing the hydrochloride salt of a fluoroquinolone derivative. It is used in the manufacturing of active pharmaceutical ingredients for research and development purposes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1246654-75-0
Isosorbide-13C6 Dinitrate
pharmaceutical raw material
N-propylpramipexole
pharmaceutical raw material
Alogliptin (13CD3)
pharmaceutical raw material
8-Chloro-11-(1-nitrosopiperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine
pharmaceutical raw material
Ent-Moxifloxacin Hydrochloride
pharmaceutical raw material
Moxifloxacin
pharmaceutical raw material
Moxifloxacin hydrochloride
pharmaceutical raw material
Moxifloxacin hydrochloride monohydrate
pharmaceutical raw material
7-(1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl)-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid;hydrochloride
IDIIJJHBXUESQI-UHFFFAOYSA-N
COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O.Cl